Laboratory Medicine and Pathology, Medical School, 2024
Regents Professor Harry T. Orr, Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota Twin Cities, is renowned for his groundbreaking work in immunology, neuroscience, and neurogenetics. He holds the James Schindler and Bob Allison Ataxia Chair in Translational Research in the Department of Laboratory Medicine and Pathology and is the director of the Institute for Translational Neuroscience.
Orr's academic journey began with a PhD in Neurobiology from Washington University in 1976, where he studied under Oliver Lowry, known for the Lowry protein assay. He then pursued postdoctoral training at Harvard University’s Department of Biochemistry and Molecular Biology, making significant contributions to understanding the amino acid sequence of human major histocompatibility antigens (HLAs), publishing in respected journals like Nature and The Proceedings of the National Academy of Sciences.
Joining the University of Minnesota in 1980, Orr continued his pioneering research on HLA, collaborating with Professor Bob DeMars from the University of Wisconsin. Together, they made crucial discoveries about the genetic map of the HLA locus, impacting tissue typing and organ transplant research. This research laid the groundwork for Orr's transition to neurogenetics, focusing on spinocerebellar ataxia (SCA), a progressive, permanent, and often fatal disease in which neurons in the brain’s cerebellum degenerate and cause the loss of balance and coordination. His scientific methodology is one of the leading models being used today for studying neurodegenerative diseases, which are increasingly prevalent in aging populations.
With over 200 research papers to his name, Orr's work is widely cited and respected, reflected in his substantial influence on neuroscience with an h-index of 88 and over 28,000 citations. He has received numerous awards and continuous federal funding, including two NIH Javits Investigator Awards (2004 and 2011), an NIH Merit Award (2022), and the Kavil Prize (2022). Orr was also appointed to the National Academies’ Institute of Medicine, now the National Academy of Medicine, in 2014, in recognition of his continued excellence in his field. As a dedicated mentor, Orr has trained 48 graduate students and postdoctoral fellows, many of whom have achieved prominent positions in academia and industry. His commitment to teaching and mentoring is evident from his receipt of the Carole J. Bland Outstanding Faculty Mentor Award (2020 and his involvement in developing genetics courses.
Beyond research and teaching, Orr has provided invaluable service to the University of Minnesota and the broader scientific community, serving on advisory boards and editorial committees. He has also held a number of leadership roles within the University, enhancing research excellence.
Orr is dedicated to promoting diversity, equity, and inclusion within the scientific community, supporting underrepresented minorities in research. His colleagues praise his humility, decency, and fairness, qualities that have significantly influenced his students and peers.
In conclusion, Orr’s career is characterized by pioneering research, exceptional mentorship, and dedicated service, transforming our understanding of neurological diseases and earning him international recognition. He exemplifies academic excellence and institutional commitment, deserving of prestigious honors.
Biographies are as-of time of award presentation.